PRECOCIOUS PUBERTY
Definition of precocious puberty
Precocious puberty is defined
as the onset of secondary
sexual characteristics before
8 yr of age in girls and 9 yr in
boys.
Classification:
Complete
Central
( gonadotropin-
dependent puberty,
GDPP)
Peripheral
(gonadotropin-
independent puberty,
GIPP)
Incomplete
Premature
thelarche
Premature
pubarche
Premature
menarche
Gonadotropin-dependent precocious
puberty ( GDPP)
also known as true precocious puberty
early activation of the entire hypothalamic-
pituitary-gonadal (HPG) axis
is caused by the secretion of high-amplitude pulses of
gonadotropin-releasing hormone (GnRH) by the
hypothalamus.
Although the onset is early, the pattern and timing of
pubertal events usually progresses in the normal
sequence.
• Non- CNS lesion:
- Idiopathic
- Genetics
-Prolonged, untreated severe hypothyroidism
• CNS lesion:
-CNS tumour
- CNS irradiation
- hydrocephalus, cysts, trauma, CNS inflammatory disease,
Gonadotropin-dependent
precocious puberty
condition occurs at least 5- to 10-fold more
frequently in girls than in boys
Approximately 90% of sexual precocity in girls is
idiopathic
75% of boys have a structural CNS
abnormality
Causes of CNS lesion:
Hypothalamic hamartomas are the most common
brain lesion causing true precocious puberty.
Hamartomas are non-malignant tumours of the tuber
cinereum that consists of disorganized collection of
neurons and glias.
ectopically located neural tissue containing GnRH-
secretory neurons and may function as an accessory
GnRH pulse generator
Other tumour: astrocytoma, optic and hypothalamic
glioma
Causes of CNS lesion: (cont.)
Radiation therapy for leukemia or intracranial
tumours  irradiation is directed to the
brain
hypothalamic
anatomically
area or to areas of the
distant from the hypothalamus 
increases the risk of precocious puberty
Clinical manifestations:
Begin at any age, follows the sequence observed in normal
puberty
In girls:
Breast enlargement comes first
Pubic hair may appear simultaneously but more often
laters
 Menarche is a late event ( irregular cycle and usually
anovulatory )
The pubertal growth spurt occurs early in female puberty
In boys:
Testicular enlargement
( unnoticed)
Enlargement of penis
Axillary hair, acne, voice
deepens
Erections are common
spermatogenesis
observed as early as 5-6
yr of age
In both gender:
weight, and osseous maturation are
Height,
advanced
Without treatment, 30% early closure of the
epiphyses > height less than the 5th percentile as
adults
Emotional and mood swings are common
In intracranial lesion ( eg: hamartoma ) :
Hypothalamic signs:
diabetes insipidus
hyperthemia
unnatural crying or laughing(gelastic seizures)
cachexia
In optic glioma : proptosis
In irradiation of brain : signs of growth hormone
deficiency may present
Gonadotropin-independent precocious
puberty ( GIPP)
Independent of gonadotropin secretion and no
activation of the HPG axis
aka precocious pseudopuberty
caused by excess secretion of sex hormones
(estrogens or androgens) derived either from the
gonads or adrenal glands or from exogenous
sources
Causes of GIPP :
Girls Boys
Ovarian cysts Leydig cell tumour
Ovarian tumours Human chorionic gonadotropin
(hCG) secreting germ cell tumors
Granulosa theca cell tmour Familial male-limited precocious
puberty
Both in boys and girl:
Exogenous estrogen
Adrenal pathology ( eg: androgen-
secreting tumour and CAH)
Teratoma
McCune-Albright syndrome
How to approach:
Onset of age?
Is the cause of precocity central or peripheral? Need to ask the
pattern of pubertal development in GDPP  normal pubertal
development but at an earlier age
How quickly is the puberty progressing?
rapid bone maturation suggest either GDPP or GIPP
Presence of headaches or seizures ? CNS lesion
Previous history of CNS disease or trauma?
Are the secondary sexual characteristics virilizing or feminizing?
 feminizing in Sertoli cell tumor
 Virilization in CAH
Any exposure to exogenous sex steroids?? (medicinal or cosmetic
sources)
Timing of pubertal onset in his or her parents and siblings? family
history of similar symptoms?
Physical examination:
Measurements of height, weight, and calculation of height velocity (cm/yr)
Pubertal staging:
 In girls:
- Breast staging, pubic hair,
 Inboys:
- Testicular volume? Penile size? Pubic hair?
Abdominal examination:
 Palpate for mass ( in ovarian cyst and tumour)
Neurological examination (neurological deficit?)
Eye examination :
 Fundoscopy :look for papilledema ( in CNSlesion)
 Visualfield
Look for signs of virilization in female? Ambigious genitalia? Hirsutism?
Dermatological exam to evaluate for cafe-au-lait spots( in McCune-Albright
syndrome).
Investigations:
Serum LH
concentration
If basal level of LH
are low or
intermediate
If LH and FSH levels
not increase with
GnRH stimulation
( GIPP)
If LH and FSH levels
increase with GnRH
stimulation
( GDPP )
If basal level of LH
are markedly elevated Confirm GDPP
Proceed with GnRH stimulation test
** Patients with GDPP must proceed with brain imaging to exclude any CNS lesion
Contrast-enhanced MRI is use to detect any hypothalamic and infundibular lesion
Other investigations:
Sex hormone
 To establish degree of biochemical pubertal enhancement
 Serum estradiol are low or undetectable in the early phase of sexual
precocity
 Serum testosterone levels are detectable or clearly elevated
Thyroid function test
- To be done if there is any clinical evidence of hypothyroidism
Radiographic assessment of bone age:
- If the patient has a normal bone age, he or she is unlikely to have
GDPP
Several ix to identify the peripheral cause of
precocious puberty ( GIPP ):
- Serum testosterone and estradiol
- Serum LH and FSH
- Renal profile (check on dehydration or electrolytes
imbalance)  in aldosterone deficiency
- Serum cortisol  to screen for Cushing syndrome
- Abdominal and pelvic ultrasound  to identify
presence of ovarian cysts or tumour
- Ultrasound of testes  possibility of Leydig cell
tumour
Management of GDPP:
The treatment options depend upon the cause of the
precocious puberty
If (GDPP) is caused by an identifiable central nervous
system (CNS) lesion therapy is directed toward the
underlying pathology
For most patients with GDPP  primary treatment
option  gonadotropin-releasing hormone
(GnRH) agonist
slows accelerated
GnRH agonist administration 
puberty and improves final height
The decision of whether to treat GDPP with a GnRH
agonist depends on:
- child’s age
- the rate of pubertal progression
- height velocity
- rate of bone age advancement.
Management for GIPP
GIPP does not respond to GnRH agonist
therapy. Instead, treatment is directed at the
underlying pathology:
Children with tumors of the testis, adrenal gland,
and ovary treated by surgery.
Those with hCG-secreting tumors  require some
combination of surgery, radiation therapy, and
chemotherapy depending upon the site and histologic
type.
Management for GIPP (cont.)
A large functioning follicular cyst of the ovary 
Cysts develop and regress spontaneously
conservative management
Children whose sexual precocity is caused by
exposure to exogenous sex steroids  exposure
identified and removed
Children with identifiable defects in adrenal
steroidogenesis ( CAH )  glucocorticoid therapy
Incomplete precocious puberty
Definition: isolated manifestations of precocity
without development of other signs of puberty.
Incomplete
Premature
thelarche
Premature
pubarche
Premature
menarche
Premature thelarche
Transient condition of isolated breast development
that most often appears in the first 2 yr of life, often
persists for 3-5 yr, and is rarely progressive
mostly  idiopathic
either remit spontaneously or are very slowly
progressive.
no other signs of pubertal development and their
growth rate is normal.
Serum estradiol : usually normal
Mx: reassurance and monitoring regularly for any
other sign of pubertal advancement
Premature pubarche
Appearance of sexual hair before the age of 8 yr in girls or 9
yr in boys without other evidence of maturation
Slowly progressive condition that requires no therapy
Longitudinal observations suggest that ~50% of affected
girls are at high risk for
 Hyperandrogenism
 Polycystic ovary syndrome
 Metabolic syndrome
Premature menarche
Diagnosis of exclusion
Isolated vaginal bleeding in the absence of other
secondary sexual characteristics
Very rare
Carefully exclude:
 Vulvovaginitis
 Foreign body
 Sexual abuse
precociouspuberty-141202210015-conversion-gate01.pptx

precociouspuberty-141202210015-conversion-gate01.pptx

  • 1.
  • 2.
    Definition of precociouspuberty Precocious puberty is defined as the onset of secondary sexual characteristics before 8 yr of age in girls and 9 yr in boys.
  • 4.
    Classification: Complete Central ( gonadotropin- dependent puberty, GDPP) Peripheral (gonadotropin- independentpuberty, GIPP) Incomplete Premature thelarche Premature pubarche Premature menarche
  • 5.
    Gonadotropin-dependent precocious puberty (GDPP) also known as true precocious puberty early activation of the entire hypothalamic- pituitary-gonadal (HPG) axis is caused by the secretion of high-amplitude pulses of gonadotropin-releasing hormone (GnRH) by the hypothalamus. Although the onset is early, the pattern and timing of pubertal events usually progresses in the normal sequence.
  • 6.
    • Non- CNSlesion: - Idiopathic - Genetics -Prolonged, untreated severe hypothyroidism • CNS lesion: -CNS tumour - CNS irradiation - hydrocephalus, cysts, trauma, CNS inflammatory disease, Gonadotropin-dependent precocious puberty
  • 7.
    condition occurs atleast 5- to 10-fold more frequently in girls than in boys Approximately 90% of sexual precocity in girls is idiopathic 75% of boys have a structural CNS abnormality
  • 8.
    Causes of CNSlesion: Hypothalamic hamartomas are the most common brain lesion causing true precocious puberty. Hamartomas are non-malignant tumours of the tuber cinereum that consists of disorganized collection of neurons and glias. ectopically located neural tissue containing GnRH- secretory neurons and may function as an accessory GnRH pulse generator Other tumour: astrocytoma, optic and hypothalamic glioma
  • 9.
    Causes of CNSlesion: (cont.) Radiation therapy for leukemia or intracranial tumours  irradiation is directed to the brain hypothalamic anatomically area or to areas of the distant from the hypothalamus  increases the risk of precocious puberty
  • 10.
    Clinical manifestations: Begin atany age, follows the sequence observed in normal puberty In girls: Breast enlargement comes first Pubic hair may appear simultaneously but more often laters  Menarche is a late event ( irregular cycle and usually anovulatory ) The pubertal growth spurt occurs early in female puberty
  • 12.
    In boys: Testicular enlargement (unnoticed) Enlargement of penis Axillary hair, acne, voice deepens Erections are common spermatogenesis observed as early as 5-6 yr of age
  • 13.
    In both gender: weight,and osseous maturation are Height, advanced Without treatment, 30% early closure of the epiphyses > height less than the 5th percentile as adults Emotional and mood swings are common
  • 14.
    In intracranial lesion( eg: hamartoma ) : Hypothalamic signs: diabetes insipidus hyperthemia unnatural crying or laughing(gelastic seizures) cachexia In optic glioma : proptosis In irradiation of brain : signs of growth hormone deficiency may present
  • 15.
    Gonadotropin-independent precocious puberty (GIPP) Independent of gonadotropin secretion and no activation of the HPG axis aka precocious pseudopuberty caused by excess secretion of sex hormones (estrogens or androgens) derived either from the gonads or adrenal glands or from exogenous sources
  • 16.
    Causes of GIPP: Girls Boys Ovarian cysts Leydig cell tumour Ovarian tumours Human chorionic gonadotropin (hCG) secreting germ cell tumors Granulosa theca cell tmour Familial male-limited precocious puberty Both in boys and girl: Exogenous estrogen Adrenal pathology ( eg: androgen- secreting tumour and CAH) Teratoma McCune-Albright syndrome
  • 17.
    How to approach: Onsetof age? Is the cause of precocity central or peripheral? Need to ask the pattern of pubertal development in GDPP  normal pubertal development but at an earlier age How quickly is the puberty progressing? rapid bone maturation suggest either GDPP or GIPP Presence of headaches or seizures ? CNS lesion Previous history of CNS disease or trauma? Are the secondary sexual characteristics virilizing or feminizing?  feminizing in Sertoli cell tumor  Virilization in CAH Any exposure to exogenous sex steroids?? (medicinal or cosmetic sources) Timing of pubertal onset in his or her parents and siblings? family history of similar symptoms?
  • 18.
    Physical examination: Measurements ofheight, weight, and calculation of height velocity (cm/yr) Pubertal staging:  In girls: - Breast staging, pubic hair,  Inboys: - Testicular volume? Penile size? Pubic hair? Abdominal examination:  Palpate for mass ( in ovarian cyst and tumour) Neurological examination (neurological deficit?) Eye examination :  Fundoscopy :look for papilledema ( in CNSlesion)  Visualfield Look for signs of virilization in female? Ambigious genitalia? Hirsutism? Dermatological exam to evaluate for cafe-au-lait spots( in McCune-Albright syndrome).
  • 19.
    Investigations: Serum LH concentration If basallevel of LH are low or intermediate If LH and FSH levels not increase with GnRH stimulation ( GIPP) If LH and FSH levels increase with GnRH stimulation ( GDPP ) If basal level of LH are markedly elevated Confirm GDPP Proceed with GnRH stimulation test
  • 20.
    ** Patients withGDPP must proceed with brain imaging to exclude any CNS lesion Contrast-enhanced MRI is use to detect any hypothalamic and infundibular lesion
  • 21.
    Other investigations: Sex hormone To establish degree of biochemical pubertal enhancement  Serum estradiol are low or undetectable in the early phase of sexual precocity  Serum testosterone levels are detectable or clearly elevated Thyroid function test - To be done if there is any clinical evidence of hypothyroidism Radiographic assessment of bone age: - If the patient has a normal bone age, he or she is unlikely to have GDPP
  • 22.
    Several ix toidentify the peripheral cause of precocious puberty ( GIPP ): - Serum testosterone and estradiol - Serum LH and FSH - Renal profile (check on dehydration or electrolytes imbalance)  in aldosterone deficiency - Serum cortisol  to screen for Cushing syndrome - Abdominal and pelvic ultrasound  to identify presence of ovarian cysts or tumour - Ultrasound of testes  possibility of Leydig cell tumour
  • 23.
    Management of GDPP: Thetreatment options depend upon the cause of the precocious puberty If (GDPP) is caused by an identifiable central nervous system (CNS) lesion therapy is directed toward the underlying pathology For most patients with GDPP  primary treatment option  gonadotropin-releasing hormone (GnRH) agonist slows accelerated GnRH agonist administration  puberty and improves final height
  • 24.
    The decision ofwhether to treat GDPP with a GnRH agonist depends on: - child’s age - the rate of pubertal progression - height velocity - rate of bone age advancement.
  • 25.
    Management for GIPP GIPPdoes not respond to GnRH agonist therapy. Instead, treatment is directed at the underlying pathology: Children with tumors of the testis, adrenal gland, and ovary treated by surgery. Those with hCG-secreting tumors  require some combination of surgery, radiation therapy, and chemotherapy depending upon the site and histologic type.
  • 26.
    Management for GIPP(cont.) A large functioning follicular cyst of the ovary  Cysts develop and regress spontaneously conservative management Children whose sexual precocity is caused by exposure to exogenous sex steroids  exposure identified and removed Children with identifiable defects in adrenal steroidogenesis ( CAH )  glucocorticoid therapy
  • 27.
    Incomplete precocious puberty Definition:isolated manifestations of precocity without development of other signs of puberty. Incomplete Premature thelarche Premature pubarche Premature menarche
  • 28.
    Premature thelarche Transient conditionof isolated breast development that most often appears in the first 2 yr of life, often persists for 3-5 yr, and is rarely progressive mostly  idiopathic either remit spontaneously or are very slowly progressive. no other signs of pubertal development and their growth rate is normal. Serum estradiol : usually normal Mx: reassurance and monitoring regularly for any other sign of pubertal advancement
  • 29.
    Premature pubarche Appearance ofsexual hair before the age of 8 yr in girls or 9 yr in boys without other evidence of maturation Slowly progressive condition that requires no therapy Longitudinal observations suggest that ~50% of affected girls are at high risk for  Hyperandrogenism  Polycystic ovary syndrome  Metabolic syndrome
  • 30.
    Premature menarche Diagnosis ofexclusion Isolated vaginal bleeding in the absence of other secondary sexual characteristics Very rare Carefully exclude:  Vulvovaginitis  Foreign body  Sexual abuse